Checklists for powder inhaler technique: A review and recommendations

Respiratory Care

Volumn 59, Issue 7, 2014, Pages 1140-1154

  Basheti, Iman A ^a   Bosnic Anticevich, Sinthia Z ^b   Armour, Carol L ^b   Reddel, Helen K ^b  

^a APPLIED SCIENCE PRIVATE UNIVERSITY   (Jordan)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Checklists; Inhalers; Pharmacists; Scoring systems; Technique

Indexed keywords

ARTICLE; DEVICE THERAPY; DRUG DELIVERY DEVICE; DRUG FORMULATION; HEALTH CARE PERSONNEL; HUMAN; PHARMACIST; POWDER INHALER; QUALITY CONTROL; RESPIRATORY THERAPEUTIC DEVICE; SCIENTIFIC LITERATURE; SCORING SYSTEM; CHECKLIST; DEVICE FAILURE; DRY POWDER INHALER; EQUIPMENT DESIGN; PACKAGING;

CHECKLIST; DRY POWDER INHALERS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMANS; PRODUCT LABELING;

EID: 84921888314     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02342     Document Type: Article

References (76)

1. Kemp JP, Hill MR, Vaughan LM, Meltzer EO, Welch MJ, Ostrom NK. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Ann Allergy Asthma Immunol 1997; 79(4): 322-326.
2. Richter K. Successful use of DPI systems in asthmatic patients-key parameters. Respir Med 2004; 98(Suppl B): S22-S27.
3. Atkins PJ. Dry powder inhalers: an overview. Respir Care 2005; 50(10): 1304-1312.
4. Roche N, Huchon GJ. Rationale for the choice of an aerosol delivery system. J Aerosol Med 2000; 13(4): 393-404.
5. Muller V, Gálffy G, Eszes N, Losonczy G, Bizzi A, Nicolini G, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med 2011; 11: 40.
6. Wetterlin K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm Res 1988; 5(8): 506-508.
7. Chrystyn H. The Diskus inhaler: A review of its pharmaceutical and clinical performance. Clin Drug Invest 1999; 18(4): 287-296.
8. Engel T, Heinig JH, Madsen F, Nikander K. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur Respir J 1990; 3(9): 1037-1041.
9. Hawksworth GM, James L, Chrystyn H. Characterization of the inspiratory manoeuvre when asthmatics inhale through a Turbohaler pre-and post-counselling in a community pharmacy. Respir Med 2000; 94(5): 501-504.
10. Lavorini F, Levy ML, Corrigan C, Crompton G, ADMIT Working Group. The ADMIT series-issues in inhalation therapy. 6 Training tools for inhalation devices. Prim Care Respir J 2010; 19(4): 335-341.
11. Kamin WE, Genz T, Roeder S, Scheuch G, Cloes R, Juenemann R, Trammer T. The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient. J Aerosol Med 2003; 16(1): 21-29.
12. Haughney J, Price D, Kaplan A, Chrystyn H, Home R, May N, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008; 102(12): 1681-1693.
13. Appel D. Faulty use of canister nebulizers for asthma. J Fam Pract 1982; 14(6): 1135-1138.
14. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns 2008; 72(1): 26-33.
15. Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasibility and acceptability of training by pharmacists. Respir Med 2011; 105(12): 1815-1822.
16. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001; 5(26): 1-149.
17. Al-Doghim I. Evaluation of inhalation technique of metered dose inhaler (MDI) and dry powder inhaler-Turbuhaler (DPI) among pediatric patients with asthma. J J Appl Sci 2007; 9(1): 53-66.
18. van der Palen J, Klein JJ, Schildkamp AM. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998; 35(2): 147-152.
19. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Counseling about Turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care 2005; 50(5): 617-623.
20. Cain WT, Cable G, Oppenheimer JJ. The ability of the community pharmacist to learn the proper actuation techniques of inhaler devices. J Allergy Clin Immunol 2001; 108(6): 918-920.
21. Chopra N, Oprescu N, Fask A, Oppenheimer J. Does introduction of new "easy to use" inhalational devices improve medical personnel's knowledge of their proper use? Ann Allergy Asthma Immunol 2002; 88(4): 395-400.
22. García-Cárdenas V, Sabater-Hernández D, García-Corpas JP, Faus MJ, Martínez-Martínez F, Benrimoj SI. Errors in Turbuhaler technique in a Spanish population of asthmatic patients (letter). Respir Care 2012; 57(5): 817-818; author reply 818-819.
23. Epstein S, Maidenberg A, Hallett D, Khan K, Chapman KR. Patient handling of a dry-powder inhaler in clinical practice. Chest 2001; 120(5): 1480-1484.
24. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical Personnel's knowledge of and ability to use inhaling devices; metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994; 105(1): 111-116.
25. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993; 104(6): 1737-1742.
26. Kamps AW, Brand PL, Roorda RJ. Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr 2002; 91(2): 159-163.
27. Khassawneh BY, Al-Ali MK, Alzoubi KH, Batarseh MZ, Al-Safi SA, Sharara AM, Alnasr HM. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. Respir Care 2008; 53(3): 324-328.
28. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003; 16(3): 249-254.
29. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 2000; 94(5): 496-500.
30. Smith IJ, Parry-Billings M. The inhalers of the future? A review of dry powder devices on the market today. Pulm Pharmacol Ther 2003; 16(2): 79-95.
31. Lareau SC, Hodder R. Teaching inhaler use in chronic obstructive pulmonary disease patients. J Am Acad Nurse Pract 2012; 24(2): 113-120.
32. Newman SP. Inhaler treatment options in COPD. Eur Respir Rev 2005; 14(96): 102-108.
33. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105(6): 930-938.
34. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004; 93(5): 439-446.
35. Moore AC, Stone S. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Han-dihaler. Int J Clin Pract 2004; 58(5): 444-450.
36. Nelson P, Young HN, Knobloch MJ, Griesbach SA. Telephonic monitoring and optimization of inhaler technique. Telemed J E Health 2011; 17(9): 734-740.
37. Nimmo CJ, Chen DN, Martinusen SM, Ustad TL, Ostrow DN. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Phar-macother 1993; 27(7-8): 922-927.
38. Rönmark E, Jögi R, Lindqvist A, Haugen T, Meren M, Loit HM, et al. Correct use of three powder inhalers: comparison between Diskus, Turbuhaler, and Easyhaler. J Asthma 2005; 42(3): 173-178.
39. Rootmensen GN, van Keimpema AR, Jansen HM, de Haan RJ. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method. J Aerosol Med Pulm Drug Deliv 2010; 23(5): 323-328.
40. van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998; 35(3): 273-279.
41. Serra-Batlles J, Plaza V, Badiola C, Morejón E, Inhalation Devices Study Group. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002; 15(1): 59-64.
42. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med 2006; 19(2): 127-136.
43. Sleath B, Ayala GX, Gillette C, Williams D, Davis S, Tudor G, et al. Provider demonstration and assessment of child device technique during pediatric asthma visits. Pediatrics 2011; 127(4): 642-648.
44. Steier J, Trammer T, Cloes RM, Petro W. Optical feedback training of inhalation with Autohaler and Turbuhaler in COPD patients. Lung 2003; 181 (4): 183-192.
45. Martin MA, Mosnaim GS, Rojas D, Hernandez O, Sadowski LS. Evaluation of an asthma medication training program for immigrant Mexican community health workers. Prog Community Health Part-nersh 2011; 5(1): 95-103.
46. Basheti IA, Qunaibi E, Bosnic-Anticevich SZ, Armour CL, Khater S, Omar M, Reddel HK. User error with Diskus and Turbuhaler by asthma patients and pharmacists in Jordan and Australia. Respir Care 2011; 56(12): 1916-1923.
47. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol 2007; 119(6): 1537-1538.
48. Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med 2010; 104(9): 1237-1245.
49. Fink JB. Inhalers in asthma management: is demonstration the key to compliance? Respir Care 2005; 50(5): 598-600.
50. Ekström T, Andersson AC, Skedinger M, Lindbladh C, Ståhl E. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler. Ann Allergy Asthma Immunol 1995; 74(4): 328-332.
51. Meakin BJ, Cainey JM, Woodcock PM. Simulated 'in-use' and 'misuse' aspects of the delivery of terbutaline sulphate from Bricanyl Turbuhaler dry powder inhalers. Int J Pharm 1995; 119(1): 103-108.
52. Hansen OR, Pedersen S. Optimal inhalation technique with terbutaline Turbuhaler. Eur Respir J 1989; 2(7): 637-639.
53. Meakin BJ, Cainey JM, Woodcock PM. Drug delivery characteristics of Bricanyl Turbohaler dry powder inhalers. Int J Pharm 1995; 119(1); 91-102.
54. Engel T, Scharling B, Heinig JH. Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes. Br J Clin Pharmacol 1992; 33(4): 439-444.
55. Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HT. The course of inhalation profiles during an exacerbation of obstructive lung disease. Respir Med 2004; 98(12): 1173-1179.
56. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102(4); 593-604.
57. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37(6): 1308-1331.
58. Borgström L, Asking L, Thorsson L. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler. Int J Clin Pract 2005; 59(12): 1488-1495.
59. Newman SP. A comparison of lung deposition patterns between different asthma inhalers. J Aerosol Med 1995; 8(Suppl 3): S21-S26; discussion S27.
60. de Boer AH, Bolhuis GK, Gjaltema D, Hagedoom P. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Int J Pharm 1997; 153(1): 67-77.
61. Persson G, Olsson B, Soliman S. The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patients. Eur Respir J 1997; 10(3): 681-684.
62. Devadason SG, Everard ML, MacEarlan C, Roller C, Summers QA, Swift P, et al. Lung deposition from the Turbuhaler in children with cystic fibrosis. Eur Respir J 1997; 10(9): 2023-2028.
63. Abdelrahim ME, Assi KH, Chrystyn H. Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow. Pharm Dev Technol 2013; 18(4): 944-949.
64. Azouz W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J 2012; 21 (2): 208-213.
65. Borgström L. On the use of dry powder inhalers in situations perceived as constrained. J Aerosol Med 2001; 14(3): 281-287.
66. Nsour WM, Alldred A, Corrado J, Chrystyn H. Measurement of peak inhalation rates with an in-check meter to identify an elderly patient's ability to use a Turbuhaler. Respir Med 2001; 95(12): 965-968.
67. Chrystyn H. Effects of device design on patient compliance: comparing the same drug in different devices. In: Dalby RN, Byron PR, Peart J, Suman JD, editors. Respiratory drug delivery Europe. Moore, Oklahoma: Davis Healthcare International Publishing; 2009: 105-116.
68. Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med 2012; 6(1): 91-101.
69. Newman SP, Pavia D, Garland N, Clarke SW. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl 1982; 119: 57-65.
70. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994; 150(5 Pt 1): 1256-1261.
71. Borgström L, Asking L, Lipniunas P. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions. J Aerosol Med 2005; 18(3): 304-310.
72. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19(2): 246-251.
73. Goren A, Noviski N, Avital A, Maayan C, Stahl E, Godfrey S, Springer C. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr Pulmonol 1994; 18(2): 77-80.
74. van der Palen J, Klein JJ, van Herwaarden CL, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J 1999; 14(5): 1034-1037.
75. Price D, Chrystyn H, Kaplan A, Haughney J, Román-Rodríguez M, Burden A, et al. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res 2012; 4(4): 184-191.
76. Williams AE, Chrystyn H. Survey of pharmacists' attitudes towards interchangeable use of dry powder inhalers. Pharm World Sci 2007; 29(3): 221-227.